AI Consensus Investment Thesis
Philip Morris (PM) Stock Forecast and AI Rating
Forecast targets and rating
Final recommendation
NEUTRAL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
NEUTRAL$191
+1.3%+4.6% incl. dividends5-Year
NEUTRAL$232
+23.1%+44.1% incl. dividendsLatest flagship insight
Smoke Free Margin Expansion Clashes With Multiple Compression Against High Yields
High consensus confirms rapid smoke-free product volume compounding and unmatched combustible pricing power will drive high-single-digit operating profit expansion. However, sharp valuation divergence centers on equity multiple contraction against five-percent benchmark bond yields, bounding five-year equity appreciation to earnings compounding alongside reliable dividends.
This is the latest published deep-analysis batch. Audit published forecasts in full transparency
Warren Buffett (Value Purist), Universal Investor (Polymath), Machiavelli (Insider), Elon Musk (Visionary), Michael Burry (Vulture), Superintelligence (Anthropologist), Sherlock Holmes (Whistleblower), J.P. Morgan (Titan), Ray Dalio (Strategist). Some archetypes run in multiple modes, resulting in 14 advisors total.
Gemini
Claude
ChatGPTExecutive Summary
Dotted terms open concise definitions. Browse technical terms
If you invested $10,000 in Philip Morris at the forecast anchor (2026-09-18): $14,405 in five years versus $13,892 for S&P 500 benchmark.
* Return is calculated incl. 3.2% net dividend yield for Philip Morris.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 187.02 | -0.85% | -0.85% | Elevated Treasury yields near 5.0% and post-rate-hike monetary tightness compress defensive valuation multiples. This macro friction absorbs the recent 8.8% dividend increase and robust ZYN shipments, leaving equity pricing essentially flat. |
| Q1 2027 | 186.65 | -0.20% | -1.05% | Seasonal post-holiday combustible volume weakness and foreign exchange headwinds create temporary profit drag. Broader multiple normalization across consumer staples pulls equity values lower despite management reaffirming high-single-digit organic constant-currency earnings guidance. |
| Q2 2027 | 188.96 | +1.24% | +0.18% | First-quarter earnings demonstrate accelerating international heated tobacco conversion across Europe and Japan. Smoke-free gross margin expansion and resilient emerging-market combustible price realization stabilize market sentiment, enabling a modest equity rebound. |
| Q3 2027 | 191.10 | +1.13% | +1.31% | Retail volume velocity accelerates ahead of the annual dividend announcement. FDA modified-risk marketing authorizations for modern oral pouches expand adult consumer conversion, driving positive earnings revisions that overcome persistent bond-yield competition. |
| Q4 2027 | 193.34 | +1.17% | +2.50% | Commercial production ramps at domestic manufacturing facilities, debottlenecking retail pouch fulfillment. Robust operating cash collections and smoke-free sales approaching 45% of group turnover generate modest capital appreciation into year-end. |
| Q1 2028 | 195.55 | +1.14% | +3.67% | State-level modern oral excise tax discussions and corporate bond refinancing at higher prevailing coupons introduce minor margin hesitation. Stable international cigarette pricing offsets regulatory drag, leaving quarterly equity performance balanced. |
| Q2 2028 | 198.71 | +1.62% | +5.35% | Commissioning of automated production lines lowers unit manufacturing costs, widening consolidated gross margins. Heated tobacco consumable adoption across secondary European metropolitan markets drives operating profit expansion above sell-side consensus. |
| Q3 2028 | 200.59 | +0.94% | +6.34% | Management delivers another high-single-digit dividend hike supported by expanding free cash conversion. Ongoing balance-sheet deleveraging toward target ratios attracts defensive institutional asset allocators, supporting steady quarterly price appreciation. |
| Q4 2028 | 202.63 | +1.02% | +7.43% | Smoke-free net revenues approach fifty percent of consolidated sales, reinforcing corporate transformation milestones. Reliable holiday cash generation and disciplined combustible pricing power defend equity valuation against broader macroeconomic deceleration. |
| Q1 2029 | 205.10 | +1.22% | +8.74% | Annual combustible pricing resets take effect across Latin America and Asia, compensating for volume attrition. Operating cash flow easily covers debt obligations, producing fractional equity gains amid a stable rate environment. |
| Q2 2029 | 209.01 | +1.90% | +10.81% | International oral nicotine rollout into emerging consumer markets gains measurable traction. Superior consumable unit economics and factory automation efficiencies expand operating income, prompting constructive institutional equity accumulation. |
| Q3 2029 | 211.14 | +1.02% | +11.94% | Predictable annual dividend compounding and free cash flow conversion exceeding 85% of operating profit reinforce defensive positioning. Steady consumer retention across smoke-free platforms drives moderate, low-volatility share price appreciation. |
| Q4 2029 | 213.11 | +0.93% | +12.98% | Selective European excise duty adjustments on modern nicotine formulations create transient sentiment friction. Strong year-end free cash flow and disciplined SG&A containment preserve profitability, keeping share performance flat to slightly positive. |
| Q1 2030 | 216.01 | +1.36% | +14.52% | Audited disclosures confirm smoke-free products generate over 52% of net revenues. Structural mix shift toward high-margin consumables cushions reported earnings against late-cycle economic cooling, supporting dependable equity compounding. |
| Q2 2030 | 219.14 | +1.45% | +16.18% | Expanding commercial adoption of next-generation heated tobacco hardware stimulates recurring consumable stick replenishment. Improved manufacturing scale efficiencies across global supply chains widen operating margins, lifting quarterly financial results. |
| Q3 2030 | 221.33 | +1.00% | +17.34% | Deleveraging milestones lower net debt ratios, unlocking balance-sheet flexibility for selective share repurchases alongside the regular dividend increase. Favorable capital return announcements provide a durable valuation floor. |
| Q4 2030 | 222.76 | +0.65% | +18.10% | Valuation multiples settle near historical staples medians of nineteen times earnings as interest rates stabilize. High-margin oral and heated product lines generate resilient cash flows, preserving price stability into calendar close. |
| Q1 2031 | 225.82 | +1.37% | +19.72% | Core international cigarette pricing power delivers reliable mid-single-digit profit gains, offsetting structural volume erosion. Sustained brand equity in premium nicotine categories ensures uninterrupted operational cash flow generation. |
| Q2 2031 | 229.41 | +1.59% | +21.63% | Smoke-free product volume dominance approaches sixty percent of group totals, reducing regulatory discount overhangs. Strong cash returns and low capital expenditure requirements drive steady quarterly equity price gains. |
| Q3 2031 | 232.12 | +1.18% | +23.06% | The five-year transformation forecast closes with the company operating as a mature smoke-free cash generator. Compounded earnings growth and reliable dividend reinvestment deliver solid cumulative total returns across normalized valuation multiples. |
The central investment thesis resolves a structural paradox: stellar operational execution across smoke-free platforms versus severe multiple compressionmultiple compressionA decline in valuation ratios such as price-to-earnings or enterprise-value-to-sales.View full glossary entry in a restrictive interest-rate regime. Smoke-free offerings, headlined by IQOS heated tobacco and ZYN modern oral pouches, now represent over 42% of net revenue, structurally elevating gross marginsgross marginsThe percentage of revenue remaining after deducting the direct costs of producing goods sold.View full glossary entry above 67%. Addictive consumer demand guarantees inelastic combustible pricing realizations of 6% to 8%, which systematically offset 2% to 4% secular cigarette volume attrition and fund high-single-digit adjusted EPS growtheps growthThe percentage increase in earnings per share over a specified period.View full glossary entry. However, equity duration acts as a powerful brake. Trading at roughly 22x forward and 27x trailing earnings, the equity offers an earnings yield barely competitive with 5.0% risk-free Treasuries, leaving zero margin of safetymargin of safetyThe difference between an estimated intrinsic value and the purchase price, intended to allow for uncertainty or analytical error.View full glossary entry. Debt refinancingdebt refinancingReplacing existing debt with new borrowing, often to change maturity, interest cost, currency, or covenants.View full glossary entry across $49 billion in liabilities with negative accounting equity further limits aggressive buybacks. Cumulative five-year equity returns will therefore be bounded by steady operating earnings compounding, tempered by multiple mean-reversion toward 18x to 20x historical staple norms.
Key insights
- Operating leverageoperating leverageThe sensitivity of operating profit to changes in revenue caused by the mix of fixed and variable costs.View full glossary entry from domestic manufacturing debottlenecking expands gross marginsgross marginsThe percentage of revenue remaining after deducting the direct costs of producing goods sold.View full glossary entry, but intensified modern oral promotional allowances will cap incremental margin conversion.
- Premium consumer staples dividend yieldsdividend yieldA financial ratio showing how much a company pays out in dividends each year relative to stock price.View full glossary entry struggle to command historical valuation premiums when risk-free sovereign debtsovereign debtDebt issued or guaranteed by a national government.View full glossary entry anchors at five percent.
- Negative accounting equity represents historical buyback capitalization rather than insolvency, yet refinancing escalating debt maturities diverts cash from share repurchases.
This business is successfully pulling off one of the biggest product transformations in history, shifting from traditional cigarettes to modern smoke-free alternatives like oral nicotine pouches and heated tobacco. These new products already generate over 40% of sales and carry much higher profit marginsprofit marginsProfit margins measure the share of revenue retained as profit after covering specified costs, expressed as a percentage.View full glossary entry. At the same time, regular price increases on legacy cigarettes easily offset falling smoking rates, creating billions in dependable cash flow to fund regular dividend hikes. The catch lies in the stock's expensive price tag. When government bonds pay 5%, paying growth-stock prices for a tobacco company rarely lasts. As the valuation multiplevaluation multipleA ratio comparing market or enterprise value with a financial measure such as earnings, revenue, book value, or cash flow.View full glossary entry gently deflates back to normal consumer-goods levels, shareholder returns will come from steady earnings growth and cash dividends rather than explosive share price spikes.
Key insights
- Modern smoke-free products make far more profit per unit than traditional cigarettes, permanently lifting company-wide earnings power.
- High interest rates make safe government bonds attractive competitors to defensive dividend stocks, limiting stock price multiple expansionmultiple expansionAn increase in valuation ratios such as price-to-earnings or enterprise-value-to-sales.View full glossary entry.
- Heavy debt from past acquisitions means cash will go toward debt service and dividends rather than massive share buybacks.
Deep Dive
Consensus market narrative treats the enterprise as an unassailable consumer-technology compoundercompounderA business or asset that can reinvest earnings or cash flows at attractive returns over an extended period.View full glossary entry deserving a premium multiple. Investors anchor on explosive ZYN pouch adoption in the United States and FDA modified-risk marketing authorizations, pricing in uninterrupted double-digit smoke-free expansion. The crowd assumes high consumer pricing powerpricing powerThe ability of a company to raise prices without losing significant customer demand.View full glossary entry effortlessly neutralizes secular combustible volume declines, while systematically ignoring multiple vulnerability against 5.0% benchmark Treasury yields and elevated debt-servicing burdens.
Paywalled preview begins: Deep Dive: detailed analysis
From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.
Deep Dive
Alpha Gap & Repricing Catalysts
Where does the current market narrative diverge from our AI Opinions—and what could close the gap?
Market Narrative
What does the market currently expect? Consensus market narrative treats the enterprise as an unassailable consumer-technology compoundercompounderA business or asset that can reinvest earnings or cash flows at attractive returns over an extended period.View full glossary entry deserving a premium multiple. Investors anchor on explosive ZYN pouch adoption in the United States and FDA modified-risk marketing authorizations, pricing in uninterrupted double-digit smoke-free expansion. The crowd assumes high consumer pricing powerpricing powerThe ability of a company to raise prices without losing significant customer demand.View full glossary entry effortlessly neutralizes secular combustible volume declines, while systematically ignoring multiple vulnerability against 5.0% benchmark Treasury yields and elevated debt-servicing burdens.
Alpha Gap
What is the biggest difference between market expectations and our AI forecasts? The crowd overestimates value by pricing the equity at 22x to 27x earnings in a restrictive monetary regimemonetary regimeThe prevailing framework of central-bank policy, interest rates, money creation, and exchange-rate management.View full glossary entry, leaving zero margin of safetymargin of safetyThe difference between an estimated intrinsic value and the purchase price, intended to allow for uncertainty or analytical error.View full glossary entry. While the market correctly recognizes operational excellence in smoke-free conversion, its blind spot is equity duration: a 3.4% dividend yielddividend yieldA financial ratio showing how much a company pays out in dividends each year relative to stock price.View full glossary entry faces asset-allocation headwinds when risk-free Treasuries yield 5.0%. Furthermore, consensus overlooks accelerating promotional discounting in modern oral nicotine and refinancing drag across $49 billion in debt, meaning multiple compressionmultiple compressionA decline in valuation ratios such as price-to-earnings or enterprise-value-to-sales.View full glossary entry will substantially absorb underlying operating profit compounding.
Repricing Catalyst
What could make the market recognize and close that gap? Successive quarterly earnings reports through 2027 will enforce valuation multiplevaluation multipleA ratio comparing market or enterprise value with a financial measure such as earnings, revenue, book value, or cash flow.View full glossary entry rationalization. Decelerating United States modern oral shipment growth alongside rising retail promotional allowances will demonstrate that category expansion requires heavy commercial reinvestment. Once investors recognize that smoke-free gross margingross marginsThe percentage of revenue remaining after deducting the direct costs of producing goods sold.View full glossary entry gains cannot fully neutralize multiple mean-reversion toward 18x to 20x historical norms, institutional capitalinstitutional capitalCapital managed by professional institutions such as pension funds, insurers, sovereign funds, endowments, or asset managers.View full glossary entry will re-rate the stock as a dependable income compoundercompounderA business or asset that can reinvest earnings or cash flows at attractive returns over an extended period.View full glossary entry rather than a premium growth platform.
Sentiment and Timing
What do sentiment, volatility, and the market-recognition cycle suggest about the thesis timing?
- Greed / Fear
- Balanced
- Volatility
- Low Steady
- Cycle position
- Overshoot
Sentiment splits between operational enthusiasm for smoke-free transformation and valuation caution regarding 5% sovereign bond yields. While operational compounders see durable momentum, multiple-sensitive analyses identify an overshoot where stock price gains will trail underlying operating profit expansion.
Macro Regime Fit
Does the current market environment support the thesis? The prevailing macroeconomic regimemacroeconomic regimeThe prevailing set of economic conditions including interest rates and inflation that influence asset pricing.View full glossary entry of restrictive central bank policy, with benchmark Treasury yields near 5.0%, constitutes a definitive valuation headwind. While addictive, price-inelastic products insulate consumer demand from inflation and allow reliable pass-through pricing, elevated sovereign yields directly penalize low-yielding consumer staples multiples. Additionally, higher borrowing costs steadily escalate debt-refinancing expenses across the company's leveraged capital structurecapital structureThe mix of debt and equity used to finance a business.View full glossary entry.
Advisor Disagreement
What do our AI Advisors disagree about most? The primary analytical disagreement concerns whether Philip Morris merits a premium consumer-growth multiplegrowth multipleGrowth multiple is a valuation premium assigned to businesses expected to sustain faster expansion than peers or the broader market.View full glossary entry or will inevitably derate toward traditional tobacco valuations. Bullish views argue that crossing 50% smoke-free revenue, combined with FDA modified-risk designations, justifies multiples above 22x earnings. Conversely, value and credit-focused perspectives maintain that competing against 5.0% risk-free Treasury yields with negative book equity and $49 billion in debt makes multiple contraction toward 18x mathematically inevitable. Resolving this tension requires tracking whether American modern oral gross profit marginsgross profit marginsThe share of revenue left after subtracting cost of goods sold.View full glossary entry re-expand as newly commissioned manufacturing scales, or continue to erode under competitive promotional discounting.
Base-Case Forces
Event Risk ScoreLow31/100Near-certain positive forces
Top Drivers / Tailwinds
Near-certain forces that support the investment thesis. These forces are treated as part of the base case (more than 60% probability of occurrence). Impact columns are specific to this asset class.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Smoke-free margin mix structural accretion | Innovation And Product | +22% | +26% | Smoke-free offerings generate over 42% of consolidated net revenues and command gross marginsgross marginsThe percentage of revenue remaining after deducting the direct costs of producing goods sold.View full glossary entry structurally superior to traditional cigarettes. As heated tobacco consumables and modern oral pouches approach half of total group volume by 2028, favorable mix shift widens consolidated above 67%, driving persistent operating income expansion despite combustible volume attrition. |
| Modern oral nicotine domestic manufacturing ramp | Operational Efficiency | +18% | +21% | Commercial scaling of the $1.2 billion automated manufacturing campus in Aurora, Colorado debottlenecks retail pouch supply shortages across North America. Domestic production eliminates expensive air-freight logistics, lowers unit cost of goods soldcost of goods soldCost of goods sold (COGS) represents the direct costs of producing or delivering the goods sold by a business.View full glossary entry, and fulfills double-digit retail offtake demand, expanding Swedish Match operating marginsoperating marginsOperating profit as a percentage of revenue after operating expenses, before interest and taxes.View full glossary entry and boosting recurring free cash conversion. |
| Combustible pricing powerpricing powerThe ability of a company to raise prices without losing significant customer demand.View full glossary entry and inelasticity | Competitive Positioning | +14% | +16% | Neurochemical demand inelasticity and dominant international brand equity allow routine 6% to 8% combustible price realizations, consistently outstripping secular 2% to 4% volume declines. This traditional tobacco cash engine generates over $10 billion in baseline annual operating income, self-funding smoke-free infrastructure investments and underwriting progressive dividend increases without dilutive external equity. |
| FDA modified risk regulatory rampart | Regulatory | +11% | +13% | FDA authorizations granting Modified Risk Tobacco Product claims for twenty oral nicotine pouch variants establish a formidable scientific and legal barrier to entry. Subscale synthetic and generic competitors cannot easily fund the multi-million-dollar toxicological dossiers required for compliance, legally protecting shelf space, retail price realization, and market share across premier convenience channels. |
Near-certain negative forces
Top Frictions / Headwinds
Near-certain forces that could slow, cap, or damage the thesis. These forces are treated as part of the base case (more than 60% probability of occurrence). Impact columns are specific to this asset class.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Valuation multiplevaluation multipleA ratio comparing market or enterprise value with a financial measure such as earnings, revenue, book value, or cash flow.View full glossary entry compression against yields | Macroeconomic And Macrofinancial | -20% | -2.0% | Trading between 22x and 27x earnings against a 5.0% 10-year Treasury yield compresses the equity risk premium. In a restrictive monetary environment, a 3.4% dividend yielddividend yieldA financial ratio showing how much a company pays out in dividends each year relative to stock price.View full glossary entry faces severe asset allocation competition from risk-free cash and bonds, exerting persistent downward gravity toward historical consumer staple valuation multiples of 18x to 20x. |
| Modern oral promotional pricing warfare | Competitive Positioning | -9.0% | -10% | Aggressive retail discounting and multi-can promotional allowances from rival brands like Velo and on! are actively challenging modern oral category pricing integrity. To defend convenience store shelf space, increased promotional allowances and trade marketing expenditures compress pouch operating marginsoperating marginsOperating profit as a percentage of revenue after operating expenses, before interest and taxes.View full glossary entry, dampening net revenue realization despite expanding consumer shipment volumes. |
| Fiscal excise tax equalization creep | Regulatory | -8.0% | -9.0% | Indebted sovereign governments confronting fiscal deficits are aggressively targeting heated tobacco and modern oral nicotine to close the excise tax differential with combustible cigarettes. Equalizing excise duties narrows the retail price advantage of reduced-risk alternatives, forcing manufacturer margin absorption and creating friction against consumer conversion velocity. |
| Leveraged balance sheetbalance sheetA financial statement showing assets, liabilities, and equity at a specific point in time.View full glossary entry refinancing drag | Capital Allocation | -7.0% | -8.0% | Carrying approximately $49 billion in funded debt and negative accounting equity following the Swedish Match transaction exposes cash flows to higher borrowing costs. Refinancing maturing debt at prevailing interest rates increases annual interest expense, absorbing operating cash flowoperating cash flowCash generated or consumed by a company's core business operations.View full glossary entry and delaying discretionary share buybacks in favor of mandatory debt service. |
What Could Break or Accelerate the Thesis
Plausible downside scenarios
Tail Risks
Tail yet plausible downside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Federal modern oral flavor prohibition | 28% | -25% | Coordinated federal or state regulatory intervention enacting sweeping bans on non-tobacco pouch flavors would severely impair consumer adoption by 2028. Because mint and fruit variants represent over 70% of pouch consumption, a comprehensive prohibition would trigger catastrophic volume contraction, stranding domestic manufacturing capacity and destroying operating profit. |
| Punitive European heated tobacco tax harmonization | 32% | -19% | An overhauled European Union Tobacco Taxation Directive mandating immediate excise duty parity between heated tobacco consumables and combustible cigarettes by 2028 would eliminate the category's consumer savings incentive. Removing the preferential tax gap would compress unit gross marginsgross marginsThe percentage of revenue remaining after deducting the direct costs of producing goods sold.View full glossary entry toward 60% and derail European smoke-free conversion momentum. |
Plausible upside scenarios
Tail Opportunities
Tail yet plausible upside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Expedited United States heated tobacco breakthrough | 34% | +22% | Rapid FDA premarket and modified-risk authorizations for the IQOS ILUMA induction platform would enable nationwide retail distribution across the lucrative American market by 2028. Capturing 5% of domestic combustible cigarette volume would unlock over $3 billion in high-margin revenue, driving double-digit operating income growth and triggering multiple re-expansion. |
| European modern oral category deregulation | 26% | +17% | A coordinated European Union regulatory reform lifting restrictions on tobacco-free nicotine pouches across key Western European member states by late 2028 would unlock a massive consumer demographic. Deploying Swedish Match infrastructure across Germany and France would rapidly expand international smoke-free volumes and drive significant upward cash-flow revisions. |
Company Financial Analysis
Philip Morris Earnings and Financials Analysis by AI
Financial figures available as of Sep 20, 2026. Only filings and source records available by this analysis date are included.
Earnings and financials
AI Review
Top-line revenue shows powerful momentum, reaching $42.5 billion over the trailing twelve months, propelled by double-digit volume expansion in smoke-free products. Heated tobacco and modern oral pouches now generate over 42% of total company sales, successfully replacing shrinking cigarette volumes. While headline accounting profits experienced temporary swings due to a $511 million non-cash investment impairment in Canada, adjusted operating income reached a robust $16.06 billion, reflecting genuine underlying business health. Free cash flow generation remained outstanding at $12.72 billion, easily funding the board's recent 8.8% dividend increase. However, growth is becoming regionally uneven. International operations continue delivering strong profit growth, while domestic oral nicotine faces heavy promotional discounting that temporarily dampens profit conversion.
Revenue, earnings, and cash flow
The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | USD 40.6B | USD 11.3B | USD 10.7B |
| 2024 | USD 37.9B | USD 7B | USD 10.8B |
| 2023 | USD 35.2B | USD 7.8B | USD 7.9B |
| 2022 | USD 31.8B | USD 9B | USD 9.7B |
| 2021 | USD 31.4B | USD 2.2B | USD 11.2B |
Valuation context: historical P/E
The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.
| Fiscal year | P/E | Earnings basis | Currency basis | Ticker / reporting |
|---|---|---|---|---|
| 2025 | 22.0x | TTM | Native | USD / USD |
| 2024 | 26.5x | TTM | Native | USD / USD |
| 2023 | 18.7x | TTM | Native | USD / USD |
| 2022 | 17.4x | Annual | Native | USD / USD |
| 2021 | 66.4x | Annual | Native | USD / USD |
P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.
Profitability and margins
AI Review
Profitability margins have expanded structurally, with gross margin widening to 67.1% and operating margin reaching 36.7%. This expansion is powered by an advantageous product mix, because heated tobacco units and oral nicotine pouches command substantially higher profit margins than conventional cigarettes. Furthermore, steady 6% to 8% price increases on traditional cigarettes reliably outpace inflation. Looking ahead, profit margin expansion will encounter natural friction. To defend market leadership against aggressive competitor discounting in convenience stores, the company has increased promotional spending on oral pouches. While overall margins remain well protected by manufacturing scale, explosive margin surprises will be harder to achieve.
The table compares up to five fiscal years of operating income and reported profitability margins.
| Fiscal year | Operating income | Operating margin | Net margin |
|---|---|---|---|
| 2025 | USD 14.9B | 36.7% | 27.9% |
| 2024 | USD 13.4B | 35.4% | 18.6% |
| 2023 | USD 11.6B | 32.9% | 22.1% |
| 2022 | USD 12.2B | 38.6% | 28.5% |
| 2021 | USD 2.9B | 9.4% | 7.1% |
Balance sheet and leverage
AI Review
The balance sheet reflects substantial financial leverage, closing with $49.1 billion in total debt and negative accounting equity of $9.99 billion. Negative book net worth is not a sign of financial distress; it is the predictable accounting result of decades of share repurchases and the debt-funded acquisition of Swedish Match. Operating cash flow covers annual interest obligations by a comfortable ten times. Nevertheless, carrying significant debt into a higher interest-rate environment requires strict capital discipline. As older, low-interest bonds mature, refinancing them at higher rates increases annual interest costs. Consequently, management must prioritize steady debt reduction toward a 2.0x leverage target, leaving little room for discretionary share repurchases.
The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.
| Fiscal year | Total debt | Cash + short-term investments | Net cash / (debt) | Current ratio |
|---|---|---|---|---|
| 2025 | USD 48.8B | USD 4.9B | USD 44B net debt | 0.96x |
| 2024 | USD 45.7B | USD 4.2B | USD 41.5B net debt | 0.88x |
| 2023 | USD 47.9B | USD 3.1B | USD 44.8B net debt | 0.75x |
| 2022 | USD 43.1B | USD 3.2B | USD 39.9B net debt | 0.72x |
| 2021 | USD 25B | USD 4.5B | USD 1.5B net cash | 4.73x |
Net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.
Capex and investment intensity
AI Review
Management maintains disciplined capital spending, directing roughly 3.9% of annual revenue, or approximately $1.6 billion, into strategic manufacturing infrastructure. The primary capital commitment is a $1.2 billion manufacturing campus in Aurora, Colorado, built to eliminate retail shortages for oral nicotine pouches. Reinvestment in legacy cigarette factories has been curtailed to focus capital where customer demand is growing. This capital-light manufacturing model delivers rapid economic paybacks. Once automated pouch and heated consumable production lines reach full design speed, unit manufacturing costs drop sharply. This high-efficiency infrastructure generates formidable competitive barriers that smaller rivals cannot easily match, protecting future free cash flow.
The table compares up to five fiscal years of capital expenditure and research-and-development investment.
| Fiscal year | Capital expenditure | R&D spend |
|---|---|---|
| 2025 | USD 1.6B | -- |
| 2024 | USD 1.4B | USD 759M |
| 2023 | USD 1.3B | USD 709M |
| 2022 | USD 1.1B | USD 642M |
| 2021 | USD 748M | USD 617M |
Quarterly Forecast Scenarios
Philip Morris Averaged Consensus Scenarios
One row per forecast quarter. Asset scenario targets are shown in USD; benchmark values are shown in USD.
Scroll to view all columns
| Quarter | Bear case (USD) | Base case (USD) | Bull case (USD) | S&P 500 benchmark (USD) |
|---|---|---|---|---|
| $181.08 | $187.27 | $194.28 | $750.26 | |
| $175.64 | $186.22 | $198.16 | $736.44 | |
| $177.40 | $188.37 | $204.11 | $743.40 | |
| $173.85 | $190.43 | $208.19 | $755.15 | |
| $177.33 | $192.61 | $212.36 | $776.22 | |
| $172.01 | $194.32 | $214.48 | $787.13 | |
| $177.17 | $197.66 | $220.91 | $802.83 | |
| $175.40 | $199.66 | $225.33 | $812.05 | |
| $178.91 | $201.79 | $229.84 | $839.18 | |
| $175.33 | $203.87 | $232.14 | $850.50 | |
| $177.08 | $207.70 | $239.10 | $872.39 | |
| $180.62 | $210.22 | $243.88 | $885.51 | |
| $178.82 | $211.93 | $248.76 | $909.56 | |
| $180.60 | $214.66 | $251.25 | $916.13 | |
| $184.22 | $217.89 | $256.27 | $936.51 | |
| $182.37 | $220.13 | $261.40 | $947.34 | |
| $186.02 | $221.70 | $266.63 | $969.59 | |
| $187.88 | $224.58 | $269.29 | $979.99 | |
| $187.88 | $228.05 | $274.68 | $999.60 | |
| $189.76 | $230.68 | $280.17 | $1,012 |
Behind the synthesis
How each opinion shapes the consensus
The independently supported consensus reveals a structural transformation where high-margin smoke-free products contribute over 42% of revenue, propelled by heated tobacco and oral nicotine pouches. Inelastic combustible pricing consistently offsets 2% to 4% secular cigarette volume attrition, generating over $12 billion in annual free cash flow that funds progressive dividend expansion. However, reports heavily correlate on valuation multiple compression as the primary friction: trading at 22x to 27x earnings against a 5.0% Treasury yield compresses the equity risk premium. The strongest contrarian perspective, modeling multiple re-expansion toward 24x on an imminent American heated-tobacco rollout, is downweighted because protracted regulatory reviews and rising promotional competition curb multiple expansion. Heavy weight is awarded to analyses verifying primary SEC filings, highlighting that H1 2026 net income volatility stemmed from non-cash equity impairments rather than operational decay. Modest weights are assigned to viewpoints projecting severe multiple collapse or unverified pharmaceutical demand destruction.
Universal Investor AI
The Polymath
Opus 5Exceptional evidentiary quality synthesizing primary SEC filings, Barclays conference updates, and the September 2026 dividend raise. Causal analysis reconciling currency-neutral EPS growth against American oral gross margin contraction provides the most realistic fundamental anchor.
Universal Investor AI
The Polymath
GPT-6 AstraOutstanding factual accuracy directly supported by June 2026 10-Q filings and FDA modified-risk documentation. Correctly distinguishes currency-adjusted operating performance from headline GAAP noise, providing realistic non-linear quarterly trajectories grounded in primary regulatory receipts.
Niccolo Machiavelli AI
The Insider
Gemini 3.8 FlashGrounded in verifiable SEC filings and industry data, highlighting domestic manufacturing debottlenecking at Aurora and Swedish Match litigation risks. It balances regulatory hurdles against unyielding combustible pricing power with sound causal logic across all five forecast years.
Sherlock Holmes AI
The Whistleblower
Gemini 3.8 FlashDemonstrates excellent empirical rigor using verified FDA filings and corporate disclosures. Identifies critical promotional discounting on modern oral pouches and dissects the non-cash Canadian impairment, grounding its realistic multiple compression thesis in authoritative evidence.
Superintelligence AI
The Anthropologist
Gemini 3.8 FlashProvides a rigorous valuation bridge linking mid-single-digit EPS expansion to sovereign bond discount rates. Correctly models multiple derating from 27x to 20x alongside robust smoke-free gross margin accretion. Slightly understates volume resilience across emerging markets.
Warren Buffett AI
The Value Seeker
Gemini 3.8 FlashArticulates a clear owner-earnings framework, emphasizing free cash flow durability and combustible pricing inelasticity against a demanding 27x entry multiple. Downweighted marginally due to generic treatment of heated tobacco technology substitution dynamics across developing markets.
Universal Investor AI
The Polymath
Gemini 3.8 FlashConstructs a robust operational narrative detailing manufacturing efficiencies from the Colorado campus alongside Swedish Match deleveraging. It captures the interplay between combustible pricing and pouch expansion, maintaining realistic expectations regarding multiple compression headwinds.
Universal Investor AI
The Polymath
Gemini 3.8 FlashPresents balanced cross-asset reasoning, reconciling 5.0% Treasury yields with negative book equity and elevated interest expenses. The thesis captures competitive oral nicotine pricing pressure accurately, though its five-year terminal enterprise multiple estimate is somewhat conservative.
Michael Burry AI
The Vulture
Gemini 3.8 FlashThorough balance-sheet forensic examination exposing negative accounting equity and higher coupon refinancing friction. Appropriately models margin compression from promotional discounting, though it excessively discounts combustible pricing power across non-dollar emerging regions.
Ray Dalio AI
The Strategist
Gemini 3.8 FlashWell-reasoned macroeconomic synthesis linking debt cycles, stagflation pricing power, and automated capacity additions. Balances multiple compression against steady 8% dividend compounding, offering sound causal explanations for durable long-term consumer staples cash flows.
Warren Buffett AI
The Value Seeker
Gemini 3.8 FlashAccurately highlights the equity risk premium deficit against five-percent risk-free yields. However, the projected multiple compression down to 18x earnings overstates terminal valuation damage by discounting proven FDA modified-risk regulatory barriers that protect category gross margins.
Elon Musk AI
The Visionary
Gemini 3.8 FlashClear technological framing of induction heating and oral pouch chemistry moats. While correctly identifying valuation friction against 5% Treasury yields, its downside scenario overestimates GLP-1 behavioral craving disruption without sufficient clinical evidence.
J.P. Morgan AI
The Titan
Gemini 3.8 FlashProvides valuable insight into industrial automation and domestic supply unlocking at Aurora. However, it overstates multiple re-expansion potential to 24x forward earnings during a restrictive monetary regime, warranting a lower relative weighting.
Superintelligence AI
The Anthropologist
Gemini 3.8 FlashOffers compelling arguments regarding biological consumer addiction moats and debt refinancing friction. However, its path models extreme equity stagnation that underweights secular international heated tobacco compounding and proven pricing power.
Research Provenance
References & Context
This Philip Morris consensus analysis combines structured market evidence with independent AI-agent forecasts. External references below are limited to sources recorded by the researcher agents for this forecast batch.
Primary analysis inputs
- iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
- iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
- Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
- Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
- Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.
Independent AI Advisor panel
- AI Advisors
- 14
- AI Researchers
- 11
- AI Thinkers
- 3
Sources retained from AI Researcher searches
Asset-specific · Researcher webShowing the top 15 of 97 deduplicated sources retained for this batch.
- 01FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim | FDAfda.gov
- 02FDA Authorizes 20 ZYN Nicotine Pouches to Be Marketed with Specific Modified Risk Claim | FDAfda.gov
- 03https://www.sec.gov/Archives/edgar/data/1413329/000162828026060806/a2026barclaysrelease.htm?utm_source=openaisec.gov
- 04Philip Morris International Inc. - Form 10-Q - FY2026sec.gov
- 05Philip Morris International Inc. - Form 8-K - FY2026sec.gov
- 06pm-20260630sec.gov
- 07We have integrated the production of our heated tobacco units into several of our existing manufacturing facilities, are progressing with our plans to build manufacturing capacity for our other SFPs, and continue to optimize our manufacturing infrastructure and expand our commercialization activities for new products and markets. We discuss certain risks related to the commercialization and supply of our SFP portfolio in Part I, Item 1A. *Risk Factors—Cautionary Factors That May Affect Future Results* in this report.sec.gov
- 08www.sec.govsec.gov
- 094 Tobacco Stocks Turning Huge Cash Flow Into High-Yield Dividends - 24/7 Wall St.247wallst.com
- 102FIRSTS | Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays2firsts.com
- 11Philip Morris stock gains as Q3 guidance and analyst support underpin sentimentad-hoc-news.de
- 12Philip Morris stock rises as 2026 outlook moves higherad-hoc-news.de
- 13Philip Morris stock trades near recent highs as Q2 2026 earnings and guidance support valuationad-hoc-news.de
- 14PM Stock Analysis 2026 - Price Target, Hold Rating & DCF Valuation · A.L. Capital Advisoryalcapitaladvisory.com
- 15Philip Morris International (NYSE:PM) Full-Year Guidance Disappoints Despite Strong Q2 Earnings Beat | ChartMill.comchartmill.com
And 82 more sources were used and retained in the batch inventory.
Context retained with this Consensus
The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.
Global context snapshot
2025 Full-Year Global Market and World-Events Context
Download Archived SnapshotCoverage 2025-01-01 to 2025-12-31 · Knowledge cutoff 2025-12-31
This full-year context package covers the principal geopolitical, economic, monetary-policy, technology, trade, energy, and institutional developments that shaped global markets during 2025. It gives the forecasting model a chronological account of major world events together with their likely transmission into growth, inflation, interest rates, supply chains, commodities, currencies, public markets, and sector-level investment conditions.
The package also includes monthly and quarterly macroeconomic and cross-asset reference tables spanning US and international growth, central-bank policy, sovereign yields, major equity indices, foreign exchange, energy, industrial and precious metals, and digital assets. Quarterly and full-year high-impact summaries are integrated; monthly quantitative series remain working values pending final audit, and that qualification is part of the preserved context.
| Top 3 Market Shifts From File | Date | Status |
|---|---|---|
| DeepSeek shock and AI economics reset | 2025-01-27 | OPEN ENDED TREND |
| US tariff regime escalation and trade-system rupture | 2025-02-01 | ACTIVE POLICY REGIME |
| Federal Reserve easing cycle after a prolonged hold | 2025-09-17 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
2026 Year-to-Date Global Market and World-Events Context Through September 20
Download Archived SnapshotCoverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20
January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.
Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.
| Top 3 Market Shifts From File | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| Tariff legal reset and strategic supply restrictions | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental context
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
12 fieldscash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields
Cash flow
5 fieldscapitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field
annual: 2014-12-31–2025-12-31, 12 periods; quarterly: 2023-09-30–2026-06-30, 12 periods
Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).
End of the paywalled preview
The excerpt from Deep Dive: detailed analysis to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.
Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.
Additional with full access
Individual AI Advisor reports
- Investment theses
- Bull and bear scenarios and alpha signals
- Drivers, headwinds, risks and opportunities
- Quarterly forecast rationale
- Advisor research references and configuration
Additional datasets and interactive tools
- Interactive forecast comparisons
- Available detailed financial statements
- Market history and corporate-action adjustments
- Eligible historical publication workspaces
Explore complete public research examples
These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.